Gregory Stephen Smith, an officer and director of Teradyne, Inc., filed a Form 144 notice of proposed sale of securities on November 16, 2026, covering 4,000 shares of Teradyne common stock with an aggregate market value of $942,880.00.

Key Highlights

  • Proposed sale: 4,000 shares of Teradyne common stock with an aggregate market value of $942,880.00.
  • Acquisition source: The shares were acquired through restricted stock vesting from the issuer on January 27, 2026, as compensation.
  • Approximate sale date: November 16, 2026, through Fidelity Brokerage Services LLC, Smithfield, Rhode Island.
  • Shares outstanding: 156,124,751 shares of Teradyne common stock were listed as outstanding at the time of filing.
  • Rule 10b5-1 plan: The filing indicates a trading plan or instruction date of February 12, 2026.
  • Recent sales history: Smith sold 4,000 shares on August 17, 2026, for gross proceeds of $1,700,000.00; 4,000 shares on September 15, 2026, for $1,351,320.00; and 4,000 shares on October 15, 2026, for $1,365,120.00.

Gregory Smith's Proposed Teradyne Share Sale Under Rule 144

According to the filing, Gregory Stephen Smith, identified as both an officer and director of Teradyne, Inc. (NASDAQ:TER), submitted a Form 144 notice of proposed sale on November 16, 2026. The notice covers 4,000 shares of Teradyne common stock to be sold through Fidelity Brokerage Services LLC, with an aggregate market value reported as $942,880.00. The filing states that the shares were acquired via restricted stock vesting from the issuer on January 27, 2026, with payment described as compensation.

The filing discloses that Smith sold Teradyne common stock three times in the preceding three months. On August 17, 2026, 4,000 shares were sold for gross proceeds of $1,700,000.00. On September 15, 2026, another 4,000 shares were sold for $1,351,320.00. On October 15, 2026, a further 4,000 shares were sold for $1,365,120.00. These prior sales are disclosed as required by Rule 144's aggregation provisions.

The notice also states that a Rule 10b5-1 trading plan or instruction was adopted or given on February 12, 2026. As stated in the filing, the signer represents that Smith "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." The filing was signed by Corey Walter as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Gregory S. Smith.

What Was Disclosed

Teradyne officer and director Gregory Stephen Smith filed a Form 144 notice to sell 4,000 shares of Teradyne common stock, acquired through restricted stock vesting, with an aggregate market value of $942,880.00, with the approximate sale date of November 16, 2026.